2015
DOI: 10.1002/jcp.25043
|View full text |Cite
|
Sign up to set email alerts
|

The Many Faces of the A2b Adenosine Receptor in Cardiovascular and Metabolic Diseases

Abstract: Modulation of the low affinity adenosine receptor subtype, the A2b adenosine receptor (A2bAR), has gained interest as a therapeutic target in various pathologic areas associated with cardiovascular disease. The actions of the A2bAR are diverse and at times conflicting depending on cell and tissue type and the timing of activation or inhibition of the receptor. The A2bAR is a promising and exciting pharmacologic target, however, a thorough understanding of A2bAR action is necessary to reach the therapeutic pote… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
21
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(21 citation statements)
references
References 97 publications
0
21
0
Order By: Relevance
“…Many cardiovascular diseases have atherosclerosis as an aetiological factor. In particular, endothelial dysfunction with the accumulation and oxidation of LDL leads to an increase in foam cells (Eisenstein et al , ). The role of adenosine receptors in the development of atherosclerosis has been investigated.…”
Section: Pathological Role Of Adenosine In Inflammatory Conditionsmentioning
confidence: 99%
“…Many cardiovascular diseases have atherosclerosis as an aetiological factor. In particular, endothelial dysfunction with the accumulation and oxidation of LDL leads to an increase in foam cells (Eisenstein et al , ). The role of adenosine receptors in the development of atherosclerosis has been investigated.…”
Section: Pathological Role Of Adenosine In Inflammatory Conditionsmentioning
confidence: 99%
“…A 2B AR may contribute to the pathogenesis of atherosclerosis. During hypoxia, A 2B AR promoted HIF-1α-induced differentiation of macrophages and foam cells (FC) in preventing atherosclerosis plaque formation [245]. Administration of BAY 60-6853 altered the lipid profile and decreased atherosclerosis in mice [189].…”
Section: A 2b Ar In Cardiovascular Systemsmentioning
confidence: 99%
“…disease [13], coronary blood flow [14], chronic heart failure [15], atherosclerosis, and dyslipidemia [16].…”
Section: Study Populationmentioning
confidence: 99%
“…A recent review highlighted that the ADORA gene members are modulators of lipid availability [12]. The physiological role of the ADORAs has been reported to be associated with lipid-related diseases, including cardiovascular disease [13], coronary blood flow [14], chronic heart failure [15], atherosclerosis, and dyslipidemia [16].…”
Section: Introductionmentioning
confidence: 99%